PIK3CA and neoplasm: The distinct mechanisms of action of isalpinin, characterized by PI3K/Akt pathway inhibition and reactive oxygen species-driven apoptosis, position it as a promising combinatorial agent, potentially facilitating reduced cisplatin dosages, thereby diminishing nephrotoxicity while preserving efficacy, and could act in concert with chemotherapeutic drugs within the tumor microenvironment.